BIM
VYNT

BlackRock Investment Management’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

BlackRock Investment Management’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3K Hold
14
– – ﹤0.01% 3846
2016
Q3 		$4K Hold
14
– – ﹤0.01% 3823
2016
Q2 		$4K Buy
14
+5
+56% +$1.76K ﹤0.01% 3902
2016
Q1 		$4K Buy
9
+2
+29% +$748 ﹤0.01% 3878
2015
Q4 		$3K Hold
7
– – ﹤0.01% 3973
2015
Q3 		$8K Hold
7
– – ﹤0.01% 3794
2015
Q2 		$12K Hold
7
– – ﹤0.01% 3653
2015
Q1 		$8K Hold
7
– – ﹤0.01% 3746
2014
Q4 		$7K Hold
7
– – ﹤0.01% 3811
2014
Q3 		$10K Hold
7
– – ﹤0.01% 3676
2014
Q2 		$11K Buy
+7
New +$13.3K ﹤0.01% 3610

Other funds holding VYNT

PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FCM
Fairbanks Capital Management Rancho Santa Fe, California $169M AUM 12.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BlackRock Investment Management's VYNT Position: Q4 2016 in Review

BlackRock Investment Management held its Vyant Bio, Inc. Common Stock (VYNT) position steady in Q4 2016 at 14 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #3846.

BlackRock Investment Management first reported a position in VYNT in Q2 2014 and has held it in 11 quarters since. The position peaked at $12K in Q2 2015. 29 funds tracked by Wall St. Rank hold VYNT as of Q4 2016.

  • BlackRock Investment Management held 14 shares of Vyant Bio, Inc. Common Stock worth $3K as of Q4 2016.
  • BlackRock Investment Management left its Vyant Bio, Inc. Common Stock share count unchanged in Q4 2016.
  • Vyant Bio, Inc. Common Stock made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3846 holding.
  • BlackRock Investment Management first reported a position in Vyant Bio, Inc. Common Stock in Q2 2014 and has held it in 11 quarters since.
  • BlackRock Investment Management's Vyant Bio, Inc. Common Stock position peaked at $12K in Q2 2015.
  • 29 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.